<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Neurol</journal-id><journal-title>BMC Neurology</journal-title><issn pub-type="epub">1471-2377</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1471-2377-9-37</article-id><article-id pub-id-type="pmid">19624857</article-id><article-id pub-id-type="doi">10.1186/1471-2377-9-37</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>An analysis of <italic>Methylenetetrahydrofolate reductase </italic>and <italic>Glutathione S-transferase omega-1 genes </italic>as modifiers of the cerebral response to ischemia</article-title></title-group><contrib-group><contrib id="A1" contrib-type="author"><name><surname>Peddareddygari</surname><given-names>Leema Reddy</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>lrpeddareddygari@solarishs.org</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Dutra</surname><given-names>Ana Virginia</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>dutracla@mskcc.org</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Levenstien</surname><given-names>Mark A</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>levenstm@mskcc.org</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Sen</surname><given-names>Souvik</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>SenS@neurology.unc.edu</email></contrib><contrib id="A5" corresp="yes" contrib-type="author"><name><surname>Grewal</surname><given-names>Raji P</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>rgrewal@solarishs.org</email></contrib></contrib-group><aff id="I1"><label>1</label>New Jersey Neuroscience Institute at JFK Medical Center, 65 James Street, Edison, New Jersey, USA</aff><aff id="I2"><label>2</label>Program in Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York, USA</aff><aff id="I3"><label>3</label>UNC Hospital Stroke Center, 7003A Neuroscience Hospital, CB 7025, Chapel Hill, North Carolina, USA</aff><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>22</day><month>7</month><year>2009</year></pub-date><volume>9</volume><fpage>37</fpage><lpage>37</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2377/9/37"/><history><date date-type="received"><day>4</day><month>5</month><year>2009</year></date><date date-type="accepted"><day>22</day><month>7</month><year>2009</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2009 Peddareddygari et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2009</copyright-year><copyright-holder>Peddareddygari et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author> Peddareddygari Reddy Leema lrpeddareddygari@solarishs.org </dc:author><dc:title> An analysis of Methylenetetrahydrofolate reductase and Glutathione S-transferase omega-1 genes as modifiers of the cerebral response to ischemia </dc:title><dc:date>2009</dc:date><dcterms:bibliographicCitation>BMC Neurology 9(1): 37-. (2009)</dcterms:bibliographicCitation><dc:identifier type="sici">1471-2377(2009)9:1&#x0003c;37&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1471-2377</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p>Cerebral ischemia involves a series of reactions which ultimately influence the final volume of a brain infarction. We hypothesize that polymorphisms in genes encoding proteins involved in these reactions could act as modifiers of the cerebral response to ischemia and impact the resultant stroke volume. The final volume of a cerebral infarct is important as it correlates with the morbidity and mortality associated with non-lacunar ischemic strokes.</p></sec><sec sec-type="methods"><title>Methods</title><p>The proteins encoded by the methylenetetrahydrofolate reductase (<italic>MTHFR</italic>) and glutathione S-transferase omega-1 (<italic>GSTO-1</italic>) genes are, through oxidative mechanisms, key participants in the cerebral response to ischemia. On the basis of these biological activities, they were selected as candidate genes for further investigation. We analyzed the C677T polymorphism in the <italic>MTHFR </italic>gene and the C419A polymorphism in the <italic>GSTO-1 </italic>gene in 128 patients with non-lacunar ischemic strokes.</p></sec><sec><title>Results</title><p>We found no significant association of either the <italic>MTHFR </italic>(p = 0.72) or <italic>GSTO-1 </italic>(p = 0.58) polymorphisms with cerebral infarct volume.</p></sec><sec><title>Conclusion</title><p>Our study shows no major gene effect of either the <italic>MTHFR </italic>or <italic>GSTO-1 </italic>genes as a modifier of ischemic stroke volume. However, given the relatively small sample size, a minor gene effect is not excluded by this investigation.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>In the United States, after cardiovascular disease and cancer, stroke is the third leading cause of death. However, it is the leading cause of morbidity resulting in about 4 million stroke survivors each year [<xref ref-type="bibr" rid="B1">1</xref>]. Although there are epidemiological differences in various ethnic groups, the majority of these strokes are ischemic rather than hemorrhagic in nature. There are a number of well established risk factors for the development of ischemic stroke including diabetes mellitus, atrial fibrillation, hypertension and age [<xref ref-type="bibr" rid="B2">2</xref>]. Once an ischemic stroke occurs, in spite of intense research efforts, little progress has been made in the discovery or development of effective neuroprotective agents.</p><p>While there are recent research efforts investigating susceptibility genes for ischemic stroke, there are few investigations of the genetics of the cerebral response to ischemia [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B4">4</xref>]. Studies of induced strokes in transgenic animals indicate that manipulation of certain genes can influence the resultant volume [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B6">6</xref>]. We hypothesize that there is variability in the cerebral response to ischemia that is mediated by polymorphisms in genes encoding proteins which participate in this response. Polymorphisms in these genes could enhance or diminish endogenous neuroprotective mechanisms and ultimately impact the volume of an ischemic stroke. This has clinical significance because, in general, the volume of a stroke correlates with severity and the resultant degree of disability of the patient [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>].</p><p>It has been established that cerebral ischemic injury results in a core of necrotic tissue surrounded by a penumbra of tissue in which neurons are functionally inactive but still potentially viable [<xref ref-type="bibr" rid="B9">9</xref>]. The development of this ischemic penumbra is limited in time by a cascade of reactions in response to the initial ischemia followed by subsequent reperfusion. Reperfusion occurring shortly after ischemia reduces infarct volume, but at a later period may exacerbate ischemic injury [<xref ref-type="bibr" rid="B10">10</xref>]. It has been suggested that reperfusion increases reactive oxygen species (ROS) production which can have further deleterious consequences. Neuronal cell exposure to these ROS, which include nitric oxide, superoxide ions and hydroxyl radicals, can result in oxidative deoxyribonucleic acid (DNA) damage [<xref ref-type="bibr" rid="B11">11</xref>-<xref ref-type="bibr" rid="B14">14</xref>].</p><p>Methylenetetrahydrofolate reductase (<italic>MTHFR</italic>) and Glutathione S-transferase omega-1(<italic>GSTO-1</italic>) are two genes that are key participants in the metabolic pathways regulating oxidative stress in the brain (Fig <xref ref-type="fig" rid="F1">1</xref>). The C677T polymorphism (NCBI SNP cluster ID rs# 1801133) in <italic>MTHFR </italic>gene results in an alanine-to-valine (A222V) substitution which in turn causes a reduction in enzyme activity and subsequent elevation of plasma homocysteine [<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B16">16</xref>]. Hyperhomocysteinemia (HHcy) has been reported as an independent risk factor for stroke but may also influence ischemic stroke volume. A study of the cerebral volume and induced stroke following middle cerebral artery occlusion in mice showed that HHcy was associated with increased oxidative damage and larger ischemic lesion [<xref ref-type="bibr" rid="B17">17</xref>-<xref ref-type="bibr" rid="B19">19</xref>]. The homocysteine (Hcy) dependent trans-sulfuration pathway is responsible for maintenance of the intracellular glutathione pool and regulation of this pathway under oxidative stress (Fig <xref ref-type="fig" rid="F1">1</xref>). GSTO-1 is member of Phase II enzymes that catalyze glutathione-dependent antioxidant pathways (Fig <xref ref-type="fig" rid="F1">1</xref>). Furthermore GSTO-1 modulates rynodyne receptors thereby protecting cells against Ca<sup>2+ </sup>induced apoptosis and inhibition of the posttranslational processing of pro-inflammatory cytokine interleukin-1&#x003b2; [<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B21">21</xref>]. The C419A (NCBI SNP cluster ID, rs 4925) polymorphism in <italic>GSTO-1 </italic>gene has been reported to be involved in stroke [<xref ref-type="bibr" rid="B22">22</xref>]. The C419A polymorphism results in amino acid alteration alanine-to-aspartate; this change in the protein sequence reduces enzyme activity and therefore could influence tissue susceptibility to oxidative stress [<xref ref-type="bibr" rid="B23">23</xref>].</p><fig position="float" id="F1"><label>Figure 1</label><caption><p><bold>The metabolic pathways regulating oxidative stress</bold>. Abbreviations: MTHFR- Methylenetetrahydrofolate reductase, THF- tetrahydro folate, Hcy- Homocysteine, SAM- S-Adenosyl methionine, eNOS-endothelial nitric oxide synthase, iNOS-inducible nitric oxide synthase, ADMA- asymmetric dimethylarginine, NO- nitric oxide, O<sub>2</sub><sup>- </sup>&#x02013; superoxide radical, ONOO<sup>- </sup>peroxinitrite, H<sub>2</sub>O<sub>2</sub>-hydrogen peroxide, NADPH &#x02013; nicotinamide adenine dinucleotide phosphate, GSTO-1- Glutathione S-transferase omega-1, GSSG -glutathione disulfide, ROOH- reduced hydroperoxides, ROH- alcohol, H<sub>2</sub>O- water.</p></caption><graphic xlink:href="1471-2377-9-37-1"/></fig><p>Given the key roles of the products of these two genes in the cerebral response to ischemia, they are candidate genes which warrant further investigation. We hypothesized that the <italic>MTHFR </italic>C677T and <italic>GSTO-1 </italic>C419A polymorphisms may modify the response of the brain to cerebral ischemia and ultimately impact the final stroke volume. To test our hypothesis we studied the relationship of these polymorphisms with infarct volume measured in patients who have suffered an ischemic stroke.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Human subjects</title><p>We studied 128 patients admitted to the stroke unit at John F. Kennedy Medical Center, Edison, New Jersey with non-lacunar ischemic infarcts. The strokes were categorized according to the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) [<xref ref-type="bibr" rid="B24">24</xref>]. Among these patients, applying the TOAST classification, the etiology of the non-lacunar ischemic strokes included 37 large artery atherothrombosis, 37 cardioembolic, 49 unknown and 5 others. In the majority of patients (79%), diffusion-weighted magnetic resonance imaging scans were available for review; alternatively, cerebral computed tomography scans (21%) were used to measure stroke volume. The stroke volume was obtained by averaging the calculated values from direct measurements of the cerebral images by two examiners as previously described [<xref ref-type="bibr" rid="B25">25</xref>]. Informed consents were obtained from the patients or their proxies and study was conducted according to protocols and methods approved by the local Institutional Review Board.</p></sec><sec><title>Genotyping</title><p>Genomic DNA was isolated from blood samples (Puregene Systems, Gentra). The <italic>MTHFR </italic>polymorphisms were genotyped as previously described [<xref ref-type="bibr" rid="B15">15</xref>]. Briefly, the primer pairs used were F: 5'-TGAAGGAGAAGGTGTCTGCGGGA-3' and R: 5'-AGGACGGTGCGGTGAGAGTG-3'. The C677T polymorphism creates a restriction site for Hinf I, so the digestion of the polymerase chain reaction (PCR) products of the mutant allele generates two fragments (175 and 23 bp). The digested products were resolved by gel electrophoresis (6% polyacrylamide gel) and the allele frequency was obtained by direct gene counting. The genotypes obtained with this method were confirmed by direct sequencing.</p><p>The <italic>GSTO-1 </italic>polymorphism was detected after PCR amplication using following primer pairs F: 5'-TGTCTAGGTGCCATCCTTGGT-3' and R: 5'-AAGTGACTTGGAAAGTGGGAA-3'. PCR was carried out in a final volume of 50 &#x003bc;l with 40 ng of DNA, 600 &#x003bc;M dNTP and 2.5 U Amplitaq gold polymerase. Thermal cycling consisted of initial activation (95&#x000b0;C for 7 min) followed by 35 cycles of denaturation (95&#x000b0;C, 30 s), annealing (56&#x000b0;C, 30 s), and extension (72&#x000b0;C, 30 s) and a final extention at 72&#x000b0;C for 7 min. PCR products were digested with restriction enzyme Cac8I at 37&#x000b0;C overnight and the digested products were resolved by gel electrophoresis (6% polyacrylamide gel). The digestion generates two fragments (147 bp and 60 bp) corresponding to C (restriction site present) and a single 207 bp product corresponding to the A allele (restriction site absent). The allele frequency was obtained by direct gene counting. The genotypes obtained with this method were confirmed by direct sequencing.</p></sec></sec><sec><title>Results</title><p>The clinical and demographic data of the study group is presented in table <xref ref-type="table" rid="T1">1</xref>. The genotypes of the <italic>MTHFR </italic>C677T and <italic>GSTO-1 </italic>C419A polymorphisms are presented in table <xref ref-type="table" rid="T2">2</xref>. The observed numbers of each genotype was compared with those expected under Hardy-Weinberg equilibrium (HWE) by using a web-based program <ext-link ext-link-type="uri" xlink:href="http://ihg.gsf.de/cgi-bin/hw/hwa1.pl"/>. No significant deviation from HWE was observed. The mean Hcy levels corresponding to each genotype is presented in the table <xref ref-type="table" rid="T3">3</xref>. Although the mean Hcy level is higher in the group with <italic>MTHFR </italic>TT genotype, it is not statistically significant. To detect the effect of the <italic>MTHFR </italic>C677T and <italic>GSTO-1 </italic>C419A polymorphisms on stroke volume ANOVA and generalized linear model analysis was done. The mean stroke volume was 71.37 cm<sup>3 </sup>(SD 90.1 cm<sup>3</sup>). There was no significant influence of the <italic>MTHFR </italic>(p = 0.72) or <italic>GSTO-1 </italic>(p = 0.58) polymorphisms on the stroke volume. The analysis was also performed for Caucasian population alone which represented 67.2% of the study population. However no significant effect of either <italic>MTHFR </italic>(p = 0.41) or <italic>GSTO-1 </italic>(p = 0.83) polymorphisms on the size of stroke was detected.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Patient characteristics. </p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left">Demographic factors</td><td></td></tr></thead><tbody><tr><td align="left">&#x02003;Female n (%)</td><td align="center">69 (52.4)</td></tr><tr><td align="left">&#x02003;Age, y mean (S.D<sup>a</sup>)</td><td align="center">70.7 (13.1)</td></tr><tr><td align="left">Ethnicity n (%)</td><td></td></tr><tr><td align="left">&#x02003;Caucasians</td><td align="center">86 (67.2)</td></tr><tr><td align="left">&#x02003;African Americans</td><td align="center">9 (7.0)</td></tr><tr><td align="left">&#x02003;Hispanics</td><td align="center">13 (10.2)</td></tr><tr><td align="left">&#x02003;Others<sup>b</sup></td><td align="center">20 (15.6)</td></tr><tr><td align="left">Co morbidities<sup>c </sup>n (%)</td><td></td></tr><tr><td align="left">&#x02003;Hypertension</td><td align="center">105 (82.0)</td></tr><tr><td align="left">&#x02003;Diabetes</td><td align="center">55 (43.0)</td></tr><tr><td align="left">&#x02003;Atrial fibrillation</td><td align="center">37 (28.9)</td></tr><tr><td align="left">&#x02003;Carotid stenosis = 70%</td><td align="center">41 (32.3)</td></tr><tr><td align="left">TOAST Classification<sup>d </sup>n (%)</td><td></td></tr><tr><td align="left">&#x02003;Large artery atherosclerosis</td><td align="center">37 (28.9)</td></tr><tr><td align="left">&#x02003;Cardiembolism</td><td align="center">37 (28.9)</td></tr><tr><td align="left">&#x02003;Unknown<sup>e</sup></td><td align="center">49 (38.3)</td></tr><tr><td align="left">&#x02003;Others</td><td align="center">5 (3.9)</td></tr></tbody></table><table-wrap-foot><p>The clinical and demographic data of the study group.</p><p><sup>a </sup>S.D = Standard deviation.</p><p><sup>b </sup>Include Asians and other ethnic groups.</p><p><sup>c </sup>Other factors studied include Coronary artery disease, Peripheral vascular disease, Lipid profile, Homocysteine levels.</p><p><sup>d </sup>TOAST = Trial of Org 10172 in Acute Stroke Treatment.</p><p><sup>e </sup>Include stroke of undetermined etiology or those due to two or more causes.</p></table-wrap-foot></table-wrap><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Genotype and stroke volume data.</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="left">Genotype</td><td align="left">N</td><td align="center">Mean stroke volume (cm<sup>3</sup>)</td></tr></thead><tbody><tr><td align="left">C677T</td><td align="left">CC</td><td align="left">49</td><td align="center">59.5</td></tr><tr><td></td><td align="left">CT</td><td align="left">60</td><td align="center">84.6</td></tr><tr><td></td><td align="left">TT</td><td align="left">18</td><td align="center">61.5</td></tr><tr><td align="left">C419A</td><td align="left">CC</td><td align="left">55</td><td align="center">72.7</td></tr><tr><td></td><td align="left">AC</td><td align="left">54</td><td align="center">74.0</td></tr><tr><td></td><td align="left">AA</td><td align="left">14</td><td align="center">63.9</td></tr></tbody></table></table-wrap><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>Genotype and homocysteine data</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="left">Genotype</td><td align="left">N</td><td align="center">Mean plasma homocysteine (&#x003bc;mol/L)</td></tr></thead><tbody><tr><td align="left"><italic>MTHFR </italic>C677T</td><td align="left">CC</td><td align="left">38</td><td align="center">10.7</td></tr><tr><td></td><td align="left">CT</td><td align="left">44</td><td align="center">10.8</td></tr><tr><td></td><td align="left">TT</td><td align="left">14</td><td align="center">11.7</td></tr><tr><td align="left"><italic>GSTO-1 </italic>C419A</td><td align="left">CC</td><td align="left">43</td><td align="center">10.7</td></tr><tr><td></td><td align="left">AC</td><td align="left">40</td><td align="center">10.7</td></tr><tr><td></td><td align="left">AA</td><td align="left">12</td><td align="center">10.3</td></tr></tbody></table></table-wrap></sec><sec><title>Discussion</title><p>Our analysis did not show a major gene effect of either the <italic>MTHFR </italic>C677T polymorphism or <italic>GSTO-1 </italic>C419A polymorphism on the volume of the ischemic infarct. However, minor genetic effects are not excluded by this study. It is possible that such minor gene effects may be additive and particular combinations of polymorphisms from different genes may confer neuroprotection. These minor gene effects could be detected by studying a much larger sample size.</p><p>In addition to investigating genes involved in the response of the brain following ischemia, there are other variables that could confound the analysis. For example, due to our relatively small sample size we did not separate and analyze the volumes of strokes occurring in a particular vascular distribution. To enhance the detection of minor gene effects, future studies could focus only upon middle cerebral artery stroke. In this study, again due to small sample size, we did not limit our analysis to those strokes of a particular etiology but rather focused upon the entire group. There may to be biological/genetic differences in the cerebral response to ischemia in cardioembolic stroke compared with large artery atherosclerosis.</p></sec><sec><title>Conclusion</title><p>In spite of the negative results, our study demonstrates the feasibility of studying the potential role of genes which participate in the cerebral response to ischemia and ultimately influence stroke volume. Many of the difficulties of any such investigation can be overcome by studying a larger sample size of patients. These studies could provide insight into endogenous neuroprotective mechanisms and facilitate the development of more effective therapies.</p></sec><sec><title>Abbreviations</title><p>MTHFR: Methylenetetrahydrofolate reductase; GSTO-1: Glutathione S-transferase omega-1; ROS: Reactive oxygen species; DNA: Deoxyribonucleic acid; HHcy: Hyperhomocysteinemia; Hcy: Homocysteine; TOAST: Trial of ORG 10172 in Acute Stroke Treatment; PCR: Polymerase chain reaction; HWE: Hardy-Weinberg equilibrium.</p></sec><sec><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec><title>Authors' contributions</title><p>LRP carried out the molecular genetic study and analysis and drafted the manuscript. AVD assisted with the molecular genetic study. ML performed the statistical analysis. SS participated in the design and finalizing the manuscript. RG participated in the design, coordination of the study and finalized the manuscript. The manuscript is read and approved by all the authors.</p></sec><sec><title>Pre-publication history</title><p>The pre-publication history for this paper can be accessed here:</p><p><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2377/9/37/prepub"/></p></sec></body><back><ack><sec><title>Acknowledgements</title><p>This study was funded by intramural funds from the New Jersey Neuroscience Institute and the Neurogenetics Foundation. We are grateful to all the Hematology laboratory personnel at JFK Medical Center, Edison, NJ for their help in collection of blood samples for this study. We also thank Dr. G.K. Dhaliwal for criticism and comments regarding this manuscript.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rosamond</surname><given-names>W</given-names></name><name><surname>Flagel</surname><given-names>K</given-names></name><name><surname>Friday</surname><given-names>G</given-names></name><name><surname>Furie</surname><given-names>K</given-names></name><name><surname>Go</surname><given-names>A</given-names></name><name><surname>Greenlund</surname><given-names>K</given-names></name><name><surname>Haase</surname><given-names>N</given-names></name><name><surname>Ho</surname><given-names>M</given-names></name><name><surname>Howard</surname><given-names>V</given-names></name><name><surname>Kissela</surname><given-names>B</given-names></name><name><surname>Kittner</surname><given-names>S</given-names></name><name><surname>Lloyd-Jones</surname><given-names>D</given-names></name><name><surname>McDermott</surname><given-names>M</given-names></name><name><surname>Meigs</surname><given-names>J</given-names></name><name><surname>Moy</surname><given-names>C</given-names></name><name><surname>Nichol</surname><given-names>G</given-names></name><name><surname>O'Donnell</surname><given-names>CJ</given-names></name><name><surname>Roger</surname><given-names>V</given-names></name><name><surname>Rumsfeld</surname><given-names>J</given-names></name><name><surname>Sorlie</surname><given-names>P</given-names></name><name><surname>Steinburger</surname><given-names>J</given-names></name><name><surname>Thom</surname><given-names>T</given-names></name><name><surname>Wasserthiel-Smoller</surname><given-names>S</given-names></name><name><surname>Hong</surname><given-names>Y</given-names></name><collab>American Heart Association Statistics Committee and Stroke Statistics Subcommittee</collab></person-group><article-title>Heart disease and stroke statistics&#x02013;2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee</article-title><source>Circulation</source><year>2007</year><volume>115</volume><fpage>e69</fpage><lpage>171</lpage><pub-id pub-id-type="pmid">17194875</pub-id><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.106.179918</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goldstein</surname><given-names>LB</given-names></name><name><surname>Adams</surname><given-names>R</given-names></name><name><surname>Becker</surname><given-names>K</given-names></name><name><surname>Furberg</surname><given-names>CD</given-names></name><name><surname>Gorelick</surname><given-names>PB</given-names></name><name><surname>Hademenos</surname><given-names>G</given-names></name><name><surname>Hill</surname><given-names>M</given-names></name><name><surname>Howard</surname><given-names>G</given-names></name><name><surname>Howard</surname><given-names>VJ</given-names></name><name><surname>Jacobs</surname><given-names>B</given-names></name><name><surname>Levine</surname><given-names>SR</given-names></name><name><surname>Mosca</surname><given-names>L</given-names></name><name><surname>Sacco</surname><given-names>RL</given-names></name><name><surname>Sherman</surname><given-names>DG</given-names></name><name><surname>Wolf</surname><given-names>PA</given-names></name><name><surname>del Zoppo</surname><given-names>GJ</given-names></name></person-group><article-title>Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association</article-title><source>Stroke</source><year>2001</year><volume>32</volume><fpage>280</fpage><lpage>99</lpage><pub-id pub-id-type="pmid">11136952</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dutra</surname><given-names>AV</given-names></name><name><surname>Lin</surname><given-names>HF</given-names></name><name><surname>Juo</surname><given-names>SH</given-names></name><name><surname>Boyadjis</surname><given-names>M</given-names></name><name><surname>Moussouttas</surname><given-names>M</given-names></name><name><surname>Reddy</surname><given-names>PL</given-names></name><name><surname>Grewal</surname><given-names>RP</given-names></name></person-group><article-title>Analysis of the endothelial nitric oxide synthase gene as a modifier of the cerebral response to ischemia</article-title><source>J Stroke Cerebrovasc Dis</source><year>2006</year><volume>15</volume><fpage>128</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">17904064</pub-id><pub-id pub-id-type="doi">10.1016/j.jstrokecerebrovasdis.2006.03.002</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dutra</surname><given-names>AV</given-names></name><name><surname>Lin</surname><given-names>HF</given-names></name><name><surname>Juo</surname><given-names>SH</given-names></name><name><surname>Mohrenweiser</surname><given-names>H</given-names></name><name><surname>Sen</surname><given-names>S</given-names></name><name><surname>Grewal</surname><given-names>RP</given-names></name></person-group><article-title>Analysis of the XRCC1 gene as a modifier of the cerebral response in ischemic stroke</article-title><source>BMC Med Genet</source><year>2006</year><volume>7</volume><fpage>78</fpage><pub-id pub-id-type="pmid">17087834</pub-id><pub-id pub-id-type="doi">10.1186/1471-2350-7-78</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>Z</given-names></name><name><surname>Huang</surname><given-names>PL</given-names></name><name><surname>Panahian</surname><given-names>N</given-names></name><name><surname>Dalkara</surname><given-names>T</given-names></name><name><surname>Fishman</surname><given-names>MC</given-names></name><name><surname>Moskowitz</surname><given-names>MA</given-names></name></person-group><article-title>Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase</article-title><source>Science</source><year>1994</year><volume>265</volume><fpage>1883</fpage><lpage>1885</lpage><pub-id pub-id-type="pmid">7522345</pub-id><pub-id pub-id-type="doi">10.1126/science.7522345</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harper</surname><given-names>AJ</given-names></name></person-group><article-title>Production of transgenic and mutant mouse models</article-title><source>Methods Mol Med</source><year>2005</year><volume>104</volume><fpage>185</fpage><lpage>202</lpage><pub-id pub-id-type="pmid">15454668</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lovblad</surname><given-names>KO</given-names></name><name><surname>Baird</surname><given-names>AE</given-names></name><name><surname>Schlaug</surname><given-names>G</given-names></name><name><surname>Benfield</surname><given-names>A</given-names></name><name><surname>Siewert</surname><given-names>B</given-names></name><name><surname>Voetsch</surname><given-names>B</given-names></name><etal></etal></person-group><article-title>Ischemic lesion volumes in acute stroke by diffusion-weighted magnetic resonance imaging correlate with clinical outcome</article-title><source>Ann Neurol</source><year>1997</year><volume>42</volume><fpage>164</fpage><lpage>170</lpage><pub-id pub-id-type="pmid">9266725</pub-id><pub-id pub-id-type="doi">10.1002/ana.410420206</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baird</surname><given-names>AE</given-names></name><name><surname>Dambrosia</surname><given-names>J</given-names></name><name><surname>Janket</surname><given-names>S</given-names></name><name><surname>Eichbaum</surname><given-names>Q</given-names></name><name><surname>Chaves</surname><given-names>C</given-names></name><name><surname>Silver</surname><given-names>B</given-names></name><name><surname>Barber</surname><given-names>PA</given-names></name><name><surname>Parsons</surname><given-names>M</given-names></name><name><surname>Darby</surname><given-names>D</given-names></name><name><surname>Davis</surname><given-names>S</given-names></name><name><surname>Caplan</surname><given-names>LR</given-names></name><name><surname>Edelman</surname><given-names>RE</given-names></name><name><surname>Warach</surname><given-names>S</given-names></name></person-group><article-title>A three-item scale for the early prediction of stroke recovery</article-title><source>Lancet</source><year>2001</year><volume>357</volume><fpage>2095</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">11445104</pub-id><pub-id pub-id-type="doi">10.1016/S0140-6736(00)05183-7</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>De Keyser</surname><given-names>J</given-names></name><name><surname>Sulter</surname><given-names>G</given-names></name><name><surname>Luiten</surname><given-names>PG</given-names></name></person-group><article-title>Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing?</article-title><source>Trends Neurosci</source><year>1999</year><volume>22</volume><fpage>535</fpage><lpage>540</lpage><pub-id pub-id-type="pmid">10542428</pub-id><pub-id pub-id-type="doi">10.1016/S0166-2236(99)01463-0</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morita-Fujimura</surname><given-names>Y</given-names></name><name><surname>Fujimura</surname><given-names>M</given-names></name><name><surname>Yoshimoto</surname><given-names>T</given-names></name><name><surname>Chan</surname><given-names>PH</given-names></name></person-group><article-title>Superoxide during reperfusion contributes to caspase-8 expression and apoptosis after transient focal stroke</article-title><source>Stroke</source><year>2001</year><volume>32</volume><fpage>2356</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">11588326</pub-id><pub-id pub-id-type="doi">10.1161/hs1001.097241</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McCord</surname><given-names>JM</given-names></name></person-group><article-title>Oxygen-derived free radicals in postischemic tissue injury</article-title><source>N Engl J Med</source><year>1985</year><volume>312</volume><fpage>159</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">2981404</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>PK</given-names></name></person-group><article-title>DNA damage and repair in the brain after cerebral ischemia</article-title><source>Curr Top Med Chem</source><year>2001</year><volume>1</volume><fpage>483</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">11895125</pub-id><pub-id pub-id-type="doi">10.2174/1568026013394688</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sugawara</surname><given-names>T</given-names></name><name><surname>Chan</surname><given-names>PH</given-names></name></person-group><article-title>Reactive oxygen radicals and pathogenesis of neuronal death after cerebral ischemia</article-title><source>Antioxid Redox Signal</source><year>2003</year><volume>5</volume><fpage>597</fpage><lpage>607</lpage><pub-id pub-id-type="pmid">14580316</pub-id><pub-id pub-id-type="doi">10.1089/152308603770310266</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gursoy-Ozdemir</surname><given-names>Y</given-names></name><name><surname>Can</surname><given-names>A</given-names></name><name><surname>Dalkara</surname><given-names>T</given-names></name></person-group><article-title>Reperfusion-induced oxidative/nitrative injury to neurovascular unit after focal cerebral ischemia</article-title><source>Stroke</source><year>2004</year><volume>35</volume><fpage>1449</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">15073398</pub-id><pub-id pub-id-type="doi">10.1161/01.STR.0000126044.83777.f4</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Frosst</surname><given-names>P</given-names></name><name><surname>Blom</surname><given-names>HJ</given-names></name><name><surname>Milos</surname><given-names>R</given-names></name><name><surname>Goyette</surname><given-names>P</given-names></name><name><surname>Sheppard</surname><given-names>CA</given-names></name><name><surname>Matthews</surname><given-names>RG</given-names></name><name><surname>Boers</surname><given-names>GJ</given-names></name><name><surname>den Heijer</surname><given-names>M</given-names></name><name><surname>Kluijtmans</surname><given-names>LA</given-names></name><name><surname>Heuvel</surname><given-names>LP van den</given-names></name><etal></etal></person-group><article-title>A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase</article-title><source>Nat Genet</source><year>1995</year><volume>10</volume><fpage>111</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">7647779</pub-id><pub-id pub-id-type="doi">10.1038/ng0595-111</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>SS</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Wong</surname><given-names>PW</given-names></name><name><surname>Kowalisyn</surname><given-names>J</given-names></name><name><surname>Strokosch</surname><given-names>G</given-names></name></person-group><article-title>Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase</article-title><source>Am J Hum Genet</source><year>1988</year><volume>43</volume><fpage>414</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">3177384</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>BO</given-names></name><name><surname>Kim</surname><given-names>NK</given-names></name><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Kang</surname><given-names>MS</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Ahn</surname><given-names>JY</given-names></name><name><surname>Kim</surname><given-names>OJ</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Oh</surname><given-names>D</given-names></name></person-group><article-title>Homozygous C677T mutation in the MTHFR gene as an independent risk factor for multiple small-artery occlusions</article-title><source>Thromb Res</source><year>2003</year><volume>111</volume><fpage>39</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">14644077</pub-id><pub-id pub-id-type="doi">10.1016/j.thromres.2003.08.022</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sacco</surname><given-names>RL</given-names></name><name><surname>Anand</surname><given-names>K</given-names></name><name><surname>Lee</surname><given-names>HS</given-names></name><name><surname>Boden-Albala</surname><given-names>B</given-names></name><name><surname>Stabler</surname><given-names>S</given-names></name><name><surname>Allen</surname><given-names>R</given-names></name><name><surname>Paik</surname><given-names>MC</given-names></name></person-group><article-title>Homocysteine and the risk of ischemic stroke in a triethnic cohort: the NOrthern MAnhattan Study</article-title><source>Stroke</source><year>2004</year><volume>35</volume><fpage>2263</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">15345803</pub-id><pub-id pub-id-type="doi">10.1161/01.STR.0000142374.33919.92</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Endres</surname><given-names>M</given-names></name><name><surname>Ahmadi</surname><given-names>M</given-names></name><name><surname>Kruman</surname><given-names>I</given-names></name><name><surname>Biniszkiewicz</surname><given-names>D</given-names></name><name><surname>Meisel</surname><given-names>A</given-names></name><name><surname>Gertz</surname><given-names>K</given-names></name></person-group><article-title>Folate deficiency increases postischemic brain injury</article-title><source>Stroke</source><year>2005</year><volume>36</volume><fpage>321</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">15625295</pub-id><pub-id pub-id-type="doi">10.1161/01.STR.0000153008.60517.ab</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dulhunty</surname><given-names>A</given-names></name><name><surname>Gage</surname><given-names>P</given-names></name><name><surname>Curtis</surname><given-names>S</given-names></name><name><surname>Chelvanayagam</surname><given-names>G</given-names></name><name><surname>Board</surname><given-names>P</given-names></name></person-group><article-title>The glutathione transferase structural family includes a nuclear chloride channel and a ryanodine receptor calcium release channel modulator</article-title><source>J Biol Chem</source><year>2001</year><volume>276</volume><fpage>3319</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">11035031</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M007874200</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Laliberte</surname><given-names>RE</given-names></name><name><surname>Perregaux</surname><given-names>DG</given-names></name><name><surname>Hoth</surname><given-names>LR</given-names></name><name><surname>Rosner</surname><given-names>PJ</given-names></name><name><surname>Jordan</surname><given-names>CK</given-names></name><name><surname>Peese</surname><given-names>KM</given-names></name><name><surname>Eggler</surname><given-names>JF</given-names></name><name><surname>Dombroski</surname><given-names>MA</given-names></name><name><surname>Geoghegan</surname><given-names>KF</given-names></name><name><surname>Gabel</surname><given-names>CA</given-names></name></person-group><article-title>Glutathione s-transferase omega 1-1 is a target of cytokine release inhibitory drugs and may be responsible for their effect on interleukin-1beta posttranslational processing</article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><fpage>16567</fpage><lpage>78</lpage><pub-id pub-id-type="pmid">12624100</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M211596200</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kolsch</surname><given-names>H</given-names></name><name><surname>Linnebank</surname><given-names>M</given-names></name><name><surname>Lutjohann</surname><given-names>D</given-names></name><name><surname>Jessen</surname><given-names>F</given-names></name><name><surname>Wullner</surname><given-names>U</given-names></name><name><surname>Harbrecht</surname><given-names>U</given-names></name><name><surname>Thelen</surname><given-names>KM</given-names></name><name><surname>Kreis</surname><given-names>M</given-names></name><name><surname>Hentschel</surname><given-names>F</given-names></name><name><surname>Schulz</surname><given-names>A</given-names></name><name><surname>von Bergmann</surname><given-names>K</given-names></name><name><surname>Maier</surname><given-names>W</given-names></name><name><surname>Heun</surname><given-names>R</given-names></name></person-group><article-title>Polymorphisms in glutathione S-transferase omega-1 and AD, vascular dementia, and stroke</article-title><source>Neurology</source><year>2004</year><volume>63</volume><fpage>2255</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">15623683</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tanaka-Kagawa</surname><given-names>T</given-names></name><name><surname>Jinno</surname><given-names>H</given-names></name><name><surname>Hasegawa</surname><given-names>T</given-names></name><name><surname>Makino</surname><given-names>Y</given-names></name><name><surname>Seko</surname><given-names>Y</given-names></name><name><surname>Hanioka</surname><given-names>N</given-names></name><name><surname>Ando</surname><given-names>M</given-names></name></person-group><article-title>Functional characterization of two variant human GSTO 1-1s (Ala140Asp and Thr217Asn)</article-title><source>Biochem Biophys Res Commun</source><year>2003</year><volume>301</volume><fpage>516</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">12565892</pub-id><pub-id pub-id-type="doi">10.1016/S0006-291X(02)03066-8</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>HP</given-names><suffix>Jr</suffix></name><name><surname>Bendixen</surname><given-names>BH</given-names></name><name><surname>Kappelle</surname><given-names>LJ</given-names></name><name><surname>Biller</surname><given-names>J</given-names></name><name><surname>Love</surname><given-names>BB</given-names></name><name><surname>Gordon</surname><given-names>DL</given-names></name><name><surname>Marsh</surname><given-names>EE</given-names><suffix>3rd</suffix></name></person-group><article-title>Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment</article-title><source>Stroke</source><year>1993</year><volume>24</volume><fpage>35</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">7678184</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kissela</surname><given-names>B</given-names></name><name><surname>Broderick</surname><given-names>J</given-names></name><name><surname>Woo</surname><given-names>D</given-names></name><name><surname>Kothari</surname><given-names>R</given-names></name><name><surname>Miller</surname><given-names>R</given-names></name><name><surname>Khoury</surname><given-names>J</given-names></name><etal></etal></person-group><article-title>Greater Cincinnati/Northern Kentucky Stroke Study: volume of first-ever ischemic stroke among blacks in a population-based study</article-title><source>Stroke</source><year>2001</year><volume>32</volume><fpage>1285</fpage><lpage>1290</lpage><pub-id pub-id-type="pmid">11387488</pub-id></citation></ref></ref-list></back></article> 